ClinConnect ClinConnect Logo
Search / Trial NCT05299736

Human Impact Exposure Onboard High-Speed Boats

Launched by GÖTEBORG UNIVERSITY · Mar 24, 2022

Trial Information

Current as of November 11, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

This is an international, observational study called the Multi-Agency Study on Human Impact Exposure Onboard High-Speed Boats (MASHIEN). Researchers want to learn which real-life impact forces on high-speed boats lead to pain or injury, by measuring what happens on the boats and to the people onboard in everyday work. They’ll analyze details like how hard impacts are, how quickly they happen, the direction of the force, and how long they last, with the goal of defining what levels are safe and maybe creating a new way to measure impact exposure.

About 250 healthy volunteers aged 17 to 70 who are volunteering crew or passengers on participating boats can join, and participation is by invitation. If you join, you’ll wear sensors on the boat and on your body and use a smartphone app to record any pain daily. You’ll be part of regular work days, not a special experiment, and there won’t be any medical treatment changes. Data are collected confidentially and shared in a secure way, with personal details made anonymous. The study is not a drug or device trial, and results are expected after an extended period of data collection, with completion around mid-2027.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • Volunteering crew or passengers working onboard or being transported in a professional capacity onboard boats used by the participating agencies and organizations
  • Exclusion Criteria:
  • • Nonvolunteering

About Göteborg University

Göteborg University, a leading academic institution in Sweden, is committed to advancing healthcare through innovative research and clinical trials. With a strong focus on interdisciplinary collaboration, the university leverages its extensive expertise in various fields, including medicine, pharmacology, and social sciences, to address pressing health challenges. By sponsoring clinical trials, Göteborg University aims to contribute to the development of new therapies and improve patient outcomes, while adhering to the highest ethical standards and regulatory requirements. Their dedication to rigorous scientific inquiry and community engagement positions them as a pivotal player in the global health research landscape.

Locations

Gothenburg, Sweden

Patients applied

0 patients applied

Trial Officials

Stephen D Myers, Professor

Study Chair

University of Chichester, Professor of Exercise Physiology

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials